These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association of MUC5B promoter polymorphism with interstitial lung changes after COVID-19: A preliminary observation. Dhooria S; Bal A; Sharma R; Prabhakar N; Arora S; Sehgal IS; Kashyap D; Garg M; Bhalla A; Aggarwal AN; Agarwal R Indian J Med Res; 2024 Jan; 159(1):109-113. PubMed ID: 38344913 [No Abstract] [Full Text] [Related]
5. Suspected Interstitial Lung Disease in COPDGene Study. Rose JA; Menon AA; Hino T; Hata A; Nishino M; Lynch DA; Rosas IO; El-Chemaly S; Raby BA; Ash SY; Choi B; Washko GR; Silverman EK; Cho MH; Hatabu H; Putman RK; Hunninghake GM Am J Respir Crit Care Med; 2023 Jan; 207(1):60-68. PubMed ID: 35930450 [No Abstract] [Full Text] [Related]
6. Associations of hiatus hernia with CT-based interstitial lung changes: the MESA Lung Study. Kim JS; Kim J; Yin X; Hiura GT; Anderson MR; Hoffman EA; Raghu G; Noth I; Manichaikul A; Rich SS; Smith BM; Podolanczuk AJ; Garcia CK; Barr RG; Prince MR; Oelsner EC Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 35777776 [TBL] [Abstract][Full Text] [Related]
7. Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts. Choi B; Adan N; Doyle TJ; San José Estépar R; Harmouche R; Humphries SM; Moll M; Cho MH; Putman RK; Hunninghake GM; Kalhan R; Liu GY; Diaz AA; Mason SE; Rahaghi FN; Pistenmaa CL; Enzer N; Poynton C; Sánchez-Ferrero GV; Ross JC; Lynch DA; Martinez FJ; Han MK; Bowler RP; Wilson DO; Rosas IO; Washko GR; San José Estépar R; Ash SY; Chest; 2023 Jan; 163(1):164-175. PubMed ID: 35780812 [TBL] [Abstract][Full Text] [Related]
8. How does the MESA Lung Study sharpen blurry edges in interstitial lung abnormalities? Brillet PY; Tran Ba S; Nunes H Eur Respir J; 2023 Jun; 61(6):. PubMed ID: 37290811 [No Abstract] [Full Text] [Related]
9. Examining the incidence of interstitial lung disease subtypes in South America. Nesset K; Kolb M J Bras Pneumol; 2024 Feb; 50(1):e20240028. PubMed ID: 38422342 [No Abstract] [Full Text] [Related]
10. Interstitial lung abnormalities: do symptoms matter? Patel AS ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37753288 [No Abstract] [Full Text] [Related]
11. Association of Acute Respiratory Disease Events with Quantitative Interstitial Abnormality Progression at CT in Individuals with a History of Smoking. Choi B; Díaz AA; San José Estépar R; Enzer N; Castro V; Han MK; Washko GR; San José Estépar R; Ash SY; Radiology; 2024 Apr; 311(1):e231801. PubMed ID: 38687222 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal assessment of interstitial lung abnormalities on CT in patients with COPD using artificial intelligence-based segmentation: a prospective observational study. Shiraishi Y; Tanabe N; Sakamoto R; Maetani T; Kaji S; Shima H; Terada S; Terada K; Ikezoe K; Tanizawa K; Oguma T; Handa T; Sato S; Muro S; Hirai T BMC Pulm Med; 2024 Apr; 24(1):200. PubMed ID: 38654252 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of interstitial lung abnormalities: a systematic review and meta-analysis. Seok J; Park S; Yoon EC; Yoon HY Sci Rep; 2024 Mar; 14(1):7330. PubMed ID: 38538680 [TBL] [Abstract][Full Text] [Related]
14. Utility of peripheral protein biomarkers for the prediction of incident interstitial features: a multicentre retrospective cohort study. Ash S; Doyle TJ; Choi B; San Jose Estepar R; Castro V; Enzer N; Kalhan R; Liu G; Bowler R; Wilson DO; San Jose Estepar R; Rosas IO; Washko GR BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38485250 [TBL] [Abstract][Full Text] [Related]
15. Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study. Choi B; Liu GY; Sheng Q; Amancherla K; Perry A; Huang X; San José Estépar R; Ash SY; Guan W; Jacobs DR; Martinez FJ; Rosas IO; Bowler RP; Kropski JA; Banovich NE; Khan SS; San José Estépar R; Shah R; Thyagarajan B; Kalhan R; Washko GR Am J Respir Crit Care Med; 2024 May; 209(9):1091-1100. PubMed ID: 38285918 [No Abstract] [Full Text] [Related]
16. The utility of quantitative computed tomography in cohort studies of chronic obstructive pulmonary disease: a narrative review. Dai Q; Zhu X; Zhang J; Dong Z; Pompeo E; Zheng J; Shi J J Thorac Dis; 2023 Oct; 15(10):5784-5800. PubMed ID: 37969311 [TBL] [Abstract][Full Text] [Related]
17. Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers. Choi B; San José Estépar R; Godbole S; Curtis JL; Wang JM; San José Estépar R; Rosas IO; Mayers JR; Hobbs BD; Hersh CP; Ash SY; Han MK; Bowler RP; Stringer KA; Washko GR; Labaki WW Respir Res; 2023 Nov; 24(1):265. PubMed ID: 37925418 [TBL] [Abstract][Full Text] [Related]
18. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Kim JS; Montesi SB; Adegunsoye A; Humphries SM; Salisbury ML; Hariri LP; Kropski JA; Richeldi L; Wells AU; Walsh S; Jenkins RG; Rosas I; Noth I; Hunninghake GM; Martinez FJ; Podolanczuk AJ Ann Am Thorac Soc; 2023 Dec; 20(12):1683-1693. PubMed ID: 37703509 [No Abstract] [Full Text] [Related]
19. Pinocchio, Interstitial Lung Abnormalities, and Becoming a Real Disease. Putman RK; Hunninghake GM Am J Respir Crit Care Med; 2023 Oct; 208(8):830-831. PubMed ID: 37698944 [No Abstract] [Full Text] [Related]